Abstract: Disclosed are immunogenic composition, fusion proteins, and related methods for inducing immune response to dengue virus infection.

Abstract: A detecting method is herein disclosed. The method includes steps of providing an eukaryotic cell, having a cell nucleus and a cell membrane, wherein the cell nucleus endogenetically translates a first receptor and a second receptor, and wherein the first receptor and the second receptor pass through the cell nucleus and translocate to the cell membrane; coupling the first receptor to a first bioactive ligand with a quantum dot; washing the cell coupled with the first bioactive ligand and the quantum dot by centrifugation; coupling the second receptor to a second bioactive ligand with a magnetic bead; washing the cell coupled with the first bioactive ligand and the second bioactive ligand by magnetic separation; irradiating a exciting energy for the quantum dot to emit a fluorescence, wherein the quantum dot coupled with the cell is excited in a pH range from pH 9 to pH 14; and detecting the fluorescence.

Abstract: A method of producing a recombinant lipidated polypeptide in E. coli. The method includes providing an E. coli host cell adapted to express a recombinant lipidated polypeptide; and culturing the E. coli host cell in a minimal medium under conditions that allow expression of the polypeptide in lipidated form.

Abstract: This invention relates to, inter alia, an isolated lipidated polypeptide including a lipid moiety at the N-terminus and a plurality of epitopes, and methods of making and using the polypeptide.

Abstract: Isolated polypeptides containing SEQ ID NO: 3 and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.

Abstract: A liquid crystal display device installed in a panel having an accommodating cavity is provided. The liquid crystal display device includes a display screen, two sliding supporters and an actuator. The display screen has a display surface parallel to the panel. The two sliding supporters connect the display screen. The actuator is disposed on a frame accommodated in the accommodating cavity to drive the two sliding supporters and the display screen moving away from the panel horizontally from a horizontal position to a destination position.

Abstract: An composition comprises (a) a continuous aqueous phase; (b) an oily phase; and (c) an amphiphilic emulsifying system comprising a block copolymer having the formula (A)p-(B)q-(C)r, in which (B)q is a hydrophilic block and (C)r is a hydrophobic block; wherein p, q and r are integers with the proviso that: if p is 0, then A is other than hydroxyl or reactive functional groups and the block copolymer is a diblock copolymer; B and C are each individual repeating) units; if p is >1, then the block copolymer is a triblock copolymer, in which (A)p is a hydrophobic block; the hydrophobic blocks (A)p and (C)r are each homopolymers or heteropolymers; the repeating units A and C are the same or different; and wherein the ratio q/(p+r) is sufficient high so that the hydrophilic-lipophilic balance value of the block copolymer is >10.

Abstract: An immunopeptide containing a T cell epitope from the tumor associated antigen L6 (TAL6) and a nucleic acid encoding the immunopeptide. The immunopeptide and its encoding nucleic acid can be used as a component of an immune composition for enhancing immune response against cancer cells that express TAL6.

Abstract: Disclosed are polypeptides and fusion proteins. Also disclosed are related immunotherapeutic compositions and methods.

Abstract: Disclosed are immunogenic composition, fusion proteins, and related methods for inducing immune response to dengue virus infection.

Abstract: Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide.

Abstract: Disclosed are lipopeptides or lipoproteins, related compositions, and related methods.

Abstract: A cell detecting system is herein disclosed, wherein a complex is formed with a first bioactive ligand coupling to a quantum dot and recognizing and coupling to a first receptor of a cell and a second bioactive ligand coupling to a magnetic bead and recognizing and coupling to a second receptor of the cell. The magnet is configured for attracting the complex. A quantum dot measuring system configured for measuring the fluorescence of the complex includes an excitation light source, an optical system, a detecting sensor and a data capturing unit, wherein the detecting sensor includes a photomultiplier tube measuring florescence of the quantum dot excited by the excitation light source. The present invention achieves the goal of specific cell detection with high sensitivity without performing cell incubation. A quantum dot measuring system is also herein disclosed.

Abstract: Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide.

Abstract: A method for detecting a target with a specific marker includes: putting a specimen in a reactor, wherein the specimen contains a target with a specific marker, and the reactor has a plurality of biological probes arranged on the bottom; placing the reactor between a first electrode and a second electrode, wherein the area of the first electrode is different from the area of the second electrode; providing a power to the first electrode and the second electrode to generate an electric field for promoting the target to conjugate with the biological probes; and removing the specimen unconjugated with the biological probes. A system for detecting a target with a specific marker is also disclosed. The above-mentioned method and system is appropriate for massive and parallel detection with simpler operation and lower cost.

Abstract: Production of a lipidated protein in an E. coli strain adapted to membrane protein expression.

Abstract: An immunopeptide containing a cytotoxic T lymphocyte epitope derived from HPV E6 or HPV E7 protein. The immunopeptide can be used as a component of a vaccine for enhancing immune responses against HPV or treating HPV-associated diseases. Also within the scope of this invention are a nucleic acid encoding the immunopeptide and an antibody specific to the CTL epitope.

Abstract: An immunogenic composition containing antigen-presenting cells and a heat shock protein or a heat shock fusion protein. Also disclosed is a method of using such a composition for enhancing cell-based immunotherapy, especially cancer immunotherapy. The method includes administering the composition to a target site.

Abstract: Isolated polypeptides containing SEQ ID NO: 3 and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.

Abstract: An immunogenic composition containing antigen-presenting cells and a heat shock protein or a heat shock fusion protein. Also disclosed is a method of using such a composition for enhancing cell-based immunotherapy, especially cancer immunotherapy. The method includes administering the composition to a target site.